Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good catch! All of our minds just read it as monotherapy since that’s all we talk about on here. Lol.
Excellent! Maybe squeeze in there somewhere about the stellar safety profile/zero adverse effects?
Thanks for all that you do here, Jedi master. :)
That was great! Thanks for sharing
Yep Doggie, me too, holding out for 10x that amount....with positive cancer data. :). Call me crazy
Vancouver is ground zero! Lol, just kidding! I live in these parts too so I can pick on myself.
Ditto. :)
Like the old saying goes “those who do not learn/study history are doomed to repeat it”.
I think they said that about measles once too....and now look at Vancouver WA go....
I was wondering what was causing this amazing bull run. Lol. Frustrating...
It’s because I have a standing order to buy on a dip to .45. Lol.
Agree, was just in the mood to call him out on the ridiculous predictability. Let’s go BPMX :)
Ditto
Saltz I keep having visions of Pestell telling Nader: “Hey, look at me. I’m the captain now.” Lol.
BOL to all of us.
Wow you must be really excited about shorting this stock today, posted your video twice in less than 5 minutes. Look at you go!
Well let's hope that Pestell and Prostagene are the two birds in the bush we need going forward....I'm hopeful.
I appreciate the examples given. However, I would prefer an appropriately-timed buy-out...with ALL of my accumulated shares included. We’ll see what happens. GL.
Of course it makes sense. I’ve just never seen it work out the way you propose, unfortunately. I would rather see an organic up-list. Like I said, let’s see what early 2019 brings and go from there. Just my opinion. Cheers!
Take a look at Diffusion Pharmaceuticals chart. DFFN. They did a reverse split on Friday, 12/14/2018....and look what has happened to the stock price since then. The day traders have a field day with it. Not sure a RS is the way to go, at least not yet. Too many things coming down the pipeline for Leronlimab that will change the dynamics here. It's not like CYDY is a NASDAQ company that must RS to regain compliance.... Lets see what the 1Q 2019 brings and go from there, IMO.
Agreed!
I’ll have to go back and listen to it a second time (obviously ha!). I had the same thought about where they are at with the company (build up as CYDY vs sell it off). Maybe they are using the pre-manufacturing and inventory build-up as a selling point, but at the same time pushing ahead to go it alone just in case. I like to think the real reason is to get Leronlimab to patients who desperately need it as soon as possible in anticipation of FDA approval, regardless.
Golden: agree, and also another point that people aren’t talking about much here that caught my ear was when Nader mentioned that a significant amount of the money they have raised is going towards ramping up the manufacturing of Leronlimab (in anticipation of FDA approval I assume). This would seem to point towards their confidence that there will be a demand for patient-ready product in the near future. It will be an interesting 1Q.
Yeah no doubt. My first thought listening to his opening statements was geez, how many martinis did he have for lunch!? Ouch
I hope you are planning to address these concerns directly with Nader (not Nadar) during the conference call on Wednesday. Might help to go straight to the source with all this consternation.
Yes! Especially a platform molecule....makes this an even bigger deal.
Really? When? Asking for a friend. :)
Cytodyn home page...scroll down to see it
Well, I’ve been here for almost 4 years, so if hanging in there for 1 or 2 more means a much, much bigger ROI, then it’s a no-brainer.
We’ll soon see how it’s all going to play out. Best of luck to us all.
Tommy you come across to me as someone here with a trader mentality and goal...meaning “let me just make my quick profit, liquidate, and move on the the next trade”.... Nothing at all wrong with that!
The thing is, this isn’t your average opportunity and I personally am here as an Investor (not as a trader), and I, like most longs recognize the enormous (possibly once-in-a-lifetime) upside potential with Leronlimab.
I am looking for this investment to change my life, not my 2018 tax return.
My apologies for sounding rude, but it seemed an odd question considering how much information you could get just by scanning the iHub posts today, thereby answering your own question. Safe travels and cheers!
Seriously?
Excellent!
I tend to think it was delayed because Pestell was overseas but who knows.
I was looking forward to attending but with the rescheduling I can’t make it on the 8th. Hopefully someone from this board will be able to attend.
But don’t forget there originally was a CC scheduled for the day after the annual SH meeting....so there obviously was more planned than just ramming through the votes
I’m curious to hear what changed....
Misiu, without going into the deep details of when/why/and how often to monitor drug therapeutic levels, I was simply adding a little background info to support the last sentence of my post, which was the point I was making. I do appreciate your input and clarity.
Saltz, to add to Misiu's comments, keep in mind, there are other medications in addition to insulin that are frequently injected subcutaneously by patients such as Lovenox and heparin (both anti-coagulants).
The common denominator for these SC injectables are that they require monitoring of the level in the body(blood) to target optimal therapy. It would seem logical that viral load levels will need periodic monitoring to guide Pro 140 therapy as well. This is not a negative, just a side note for guidance to proper dosing. Patients world-wide are used to the idea of self-injectable medications and subsequent blood draws to guide therapy. There is obviously a roadblock (or two) to this (drug) being catapulted to actual value, but I highly doubt that the injectable delivery method is culpable. IMO.
Is it just me, or did everyone else read Nader's quotes in his voice??? Lol...
With that being the case, I would be very surprised if enough NO votes are cast to halt the compensation proposal (for Nader). We will find out soon enough I suppose.
Just FYI: voting “NO” (or Yes) for compensation isn’t a hard stop item...it is only an advisement to the BOD which they will then consider and do whatever they want anyways, no matter how many shareholders vote “NO”.